About Arene Life Sciences Private Limited
Data last updated:
Arene Life Sciences Private Limited is a private limited company based in Sangareddy, Telangana, India, a subsidiary of S.R. Drugs And Intermediates Pvt.Ltd.. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 17 September 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC044199. Its GSTIN is 36AAFCA3106K1ZW (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹75 Cr and a paid-up capital of ₹37.4 Cr. It was formerly known as Arene Life Sciences Limited. It is led by directors including Satyanarayana Reddy Khairtabad (Managing Director) and Santosh Reddy Chinnamail.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sangareddy, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹497.82 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹20.81 Cr (net margin 4.2%) and EBITDA of ₹43.58 Cr (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 5% over five years.
The company has about 593 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Arene Life Sciences and Arene Lifesciences. As per MCA filings, the company has open charges of ₹122.4 Cr and satisfied charges of ₹36.94 Cr on record. Court records list 14 cases involving the company, including 7 filed by the company and 3 filed against it; 3 cases are pending. The company has 16 deals on record (10 secondary share transfers, 4 rights issues, 2 funding rounds), with disclosed funding of ₹19.95 Cr; the latest was in August 2024. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is G.C. Chemie Pharmie Limited with revenue of ₹556.64 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arenelifesciences.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.49 50 209&210, Phase II, Sangareddy, Telangana, India – 502307
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Arene Life Sciences Private Limited
The main business activity of Arene Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Arene Life Sciences Private Limited FY 2025 filings available
Arene Life Sciences Private Limited reported revenue of ₹497.82 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Arene Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 23% growth in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Arene Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹43.58 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹20.81 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Arene Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Arene Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Arene Life Sciences Private Limited
Arene Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| G.C. Chemie Pharmie Limited | ₹556.64 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Maithri Laboratories Private Limited | ₹535.6 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Raichem Medicare Private Limited | ₹515.04 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Chicksugur Village, Karnataka, India |
| Pharmazell (India) Private Limited | ₹510.27 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Chennai, Tamil Nadu, India |
| Sudarshan Pharma Industries Limited | ₹507.57 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Arene Life Sciences Private Limited this company | ₹497.82 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Sangareddy, Telangana, India |
| Milagro Life Sciences Private Limited | ₹497.15 Cr (FY 2023) | •••• | •••• | 1347099.0% | •••• | Mumbai, Maharashtra, India |
| Apac Trade Private Limited | ₹488.26 Cr (FY 2023) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Aarey Drugs and Pharmaceuticals Limited Listed | ₹483.76 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Thane, Maharashtra, India |
| Aurore Life Sciences Private Limited | ₹471.23 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| CTX Lifesciences Private Limited | ₹464.3 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Surat, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Arene Life Sciences by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Arene Life Sciences Private Limited
Arene Life Sciences Private Limited is audited by V R R & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V R R & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Arene Life Sciences Private Limited
Arene Life Sciences has 4 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyanarayana Reddy Khairtabad Also directs: Srduo Infra LLP, Satya Sharada Ventures LLP, S.R. Drugs and Intermediates Pvt.Ltd. and 5 more | Managing Director | 17 Sep 2004 | 22 Years 1 Months | Current |
| Santosh Reddy Chinnamail | Director | 06 Sep 2019 | 7 Years 1 Months | Current |
| Khairtabad Anuraag Reddy | Director | 06 Sep 2019 | 7 Years 1 Months | Current |
| Satyanarayana Reddy Chinnamail Also directs: Srduo Infra LLP, S.R. Drugs and Intermediates Pvt.Ltd., S.R. Drugs and Intermediates (Unit 3) Private Limited and 5 more | Director | 17 Sep 2004 | 22 Years 1 Months | Current |
Ownership and Shareholding of Arene Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Arene Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2024 | Others | ₹14.1 Cr | Open |
| 08 Dec 2023 | Hdfc Bank Limited | ₹22.32 Lakh | Open |
| 31 Aug 2023 | Others | ₹20 Cr | Open |
| 30 Dec 2021 | Karnataka Bank Ltd. | ₹8.9 Cr | Open |
| 21 Apr 2020 | Karnataka Bank Ltd. | ₹47.5 Cr | Open |
Total charge records: 9 View all charges
Deals & Funding of Arene Life Sciences Private Limited
Arene Life Sciences Private Limited has 16 deals on record (10 secondary share transfers, 4 rights issues, 2 funding rounds), with disclosed funding of ₹19.95 Cr; the latest was in August 2024.
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2024 | Rights issue | ₹10.22 Cr | Investors: S.R. Drugs and Intermediates Pvt.Ltd. |
| Dec 2020 | Secondary share transfer | Undisclosed | Buyer: S.R. Drugs and Intermediates Pvt.Ltd. , 2 individuals Seller: Arene Life Sciences (Unit 3) Private Limited , an individual |
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: S.R. Drugs and Intermediates Pvt.Ltd. Seller: an individual |
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: S.R. Drugs and Intermediates Pvt.Ltd. Seller: an individual |
| Jul 2019 | Secondary share transfer | Undisclosed | Buyer: S.R. Drugs and Intermediates Pvt.Ltd. Seller: an individual |
Full deal history
All 16 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Arene Life Sciences Private Limited
Arene Life Sciences Private Limited has 14 court cases on record: 7 filed by Arene Life Sciences, 3 filed against it, 4 where it is another party. 3 cases are pending and 11 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 2 | 0 |
| District courts | 7 | 1 | 3 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sangareddy, Telangana | Cheque dishonour complaint | Filed by the company against Centurion Laboratories Private Limited | Pending |
| District court, Sangareddy, Telangana | Cheque dishonour complaint | Filed by the company against Aurore Life Sciences Private Limited | Pending |
| District court, Sangareddy, Telangana | Cheque dishonour complaint | Filed by the company against Centurion Laboratories Private Limited | Pending |
| District court, Sangareddy, Telangana | Cheque dishonour complaint | Filed by the company against Aparna Organics Limited | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against an individual | Disposed |
Full case history
All 14 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Arene Life Sciences Private Limited
Arene Life Sciences operates two associated brands: Arene Life Sciences and Arene Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures Active Pharmaceutical Ingredients with expertise in reactions and customization for clients. | arenelifesciences.com | |
| Pharmaceutical manufacturing of APIs and intermediates with job opportunities in various sectors. | pharmajobsportal.in |
Employees and EPFO Compliance at Arene Life Sciences Private Limited
Arene Life Sciences Private Limited has a workforce of 593 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Name History of Arene Life Sciences Private Limited
Arene Life Sciences has undergone 2 name changes throughout its history. The company was previously known as Arene Life Sciences Private Limited, and Arene Life Sciences Limited. The current legal name is Arene Life Sciences Private Limited.
| Company Name | Status |
|---|---|
| Arene Life Sciences Private Limited | Current |
| Arene Life Sciences Limited | Previous |
CIN History of Arene Life Sciences Private Limited
Arene Life Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TG2004PTC044199, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC044199 | Current |
| U24239AP2004PLC044199 | Previous |
| U24239TG2004PLC044199 | Previous |
Recent Activity on Arene Life Sciences Private Limited
Arene Life Sciences Private Limited has 17 board changes on record since 2004: 4 appointments and 13 cessations. The latest: Narayan Shiva Reddy Moranganti ceased to be Director on 14 Sep 2020.
24 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Arene Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Arene Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Arene Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Arene Life Sciences Private Limited
Arene Life Sciences has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCA3106K1ZW | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Arene Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Arene Life Sciences Private Limited
Frequently Asked Questions about Arene Life Sciences Private Limited
Arene Life Sciences is an active private limited company based in Sangareddy, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 17 September 2004 (22+ years old) and is registered under CIN U24239TG2004PTC044199.
Arene Life Sciences reported revenue of ₹497.82 Cr for FY 2025 (up 23% YoY).
Arene Life Sciences has 4 current directors:
- Satyanarayana Reddy Khairtabad - Managing Director
- Santosh Reddy Chinnamail - Director
- Khairtabad Anuraag Reddy - Director
- Satyanarayana Reddy Chinnamail - Director
Arene Life Sciences reported a net profit of ₹20.81 Cr (net margin 4.2%) and EBITDA of ₹43.58 Cr (EBITDA margin 8.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Arene Life Sciences is 10% over three years and 5% over five years. In the latest year (FY 2025) revenue rose 23%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Arene Life Sciences is 36AAFCA3106K1ZW, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Arene Life Sciences is U24239TG2004PTC044199. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arene Life Sciences has 14 court cases on record: 7 filed by the company and 3 filed against it. 3 are pending. Most are in the high courts.
Arene Life Sciences was incorporated on 17 September 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Arene Life Sciences has 16 deals on record (10 secondary share transfers, 4 rights issues, 2 funding rounds), with disclosed funding of ₹19.95 Cr; the latest was in August 2024.
The peers of Arene Life Sciences by revenue are G.C. Chemie Pharmie Limited, Maithri Laboratories Private Limited, Raichem Medicare Private Limited, Pharmazell (India) Private Limited, Sudarshan Pharma Industries Limited and 5 more, all in the Pharma industry (API Manufacturers).